Immune therapy struggled for years with just occasional small gains, but “now we have cruise missiles” giving better kill rates against many tumor types, said Dr. Steven O’Day of the University of Southern California.
Others tempered their enthusiasm, noting that some promising approaches produced more limited gains once they were more fully researched.
“Let’s not forget the history” of what seems like progress with a new approach, said Dr. Len Lichtenfeld, deputy chief medical officer of the American Cancer Society. “It doesn’t always work out the way it appears to be heading.”
National Cancer Institute: http://tinyurl.com/o5p6ahb
Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP
Breaking news, severe weather alerts, AMBER alerts, sports scores from The Norman Transcript are available as text messages right to your phone or mobile device. You decide which type of alerts you want to receive. Find out more or to signup, click here.